David Drutz, Director at Altimmune, Inc. (ALT), bought 9,000 shares at $4.27 ($38K) on 2023-03-23, disclosed to the SEC on 2023-03-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| Filing → |
| ALT | BUY | 2022-06-16 | $8K | — | Filing → |
| ALT | BUY | 2022-05-25 | $5K | — | Filing → |
| ALT | BUY | 2017-08-24 | $22K | — | Filing → |